Literature DB >> 30738693

Molecular characterization of "sessile serrated" adenoma to carcinoma transition in six early colorectal cancers.

Rocco Cappellesso1, Marcello Lo Mele1, Giada Munari2, Erik Rosa-Rizzotto3, Ennio Guido3, Franca De Lazzari3, Pierluigi Pilati4, Marco Tonello5, Fabio Farinati6, Stefano Realdon7, Matteo Fassan8, Massimo Rugge1.   

Abstract

Colorectal cancer (CRC) is a heterogeneous group of diseases both from the morphological and molecular point of view. The sessile serrated adenoma/polyp (SSA/P) has been proposed as the precursor lesion of CRCs characterized by CpG island methylator phenotype (CIMP), DNA mismatch repair (MMR) system deficiency, and BRAF gene mutations. However, no study so far investigated the molecular landscape of "sessile serrated" adenoma to carcinoma transition in early CRCs. Six formalin-fixed paraffin-embedded CRCs developed within SSA/P were profiled for the immunohistochemical expression of MMR proteins (MLH1, MSH2, MSH6, PMS2, and Ep-CAM), p16, and β-catenin. DNA was extracted from the two components of each sample, after microdissection, and characterized for CIMP status and by applying a custom hotspot multigene mutational profiling of 164 hotspot regions of eleven CRC-associated genes (AKT1, APC, BRAF, CTNNB1, KIT, KRAS, NRAS, PDGFRA, PIK3CA, PTEN, and TP53). Five out of the six CRCs shared the same molecular profile (i.e. CIMP positive, MSI status, and BRAF mutation) with their SSA/P components. One out of five CRCs was also APC mutated, whereas another one showed an additional TP53 mutation. The remaining case was CIMP negative and MMR proficient in both the components, harbored a BRAF mutation in the SSA/P counterpart, whereas the CRC one was APC and TP53 mutated and showed p16 and β-catenin dysregulation. This study provides the molecular evidence that SSA/P, even without cytological dysplasia, is a precursor lesion of CRC and that conventional CRC might arise from mixed polyp.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  BRAF; CIMP; Colorectal; Mismatch repair system; Sessile serrated adenoma/polyp

Mesh:

Year:  2019        PMID: 30738693     DOI: 10.1016/j.prp.2019.02.001

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  6 in total

1.  Somatic Mutations in Exon 7 of the TP53 Gene in Index Colorectal Lesions Are Associated with the Early Occurrence of Metachronous Adenoma.

Authors:  Tereza Hálková; Renata Ptáčková; Anastasiya Semyakina; Štěpán Suchánek; Eva Traboulsi; Ondřej Ngo; Kateřina Hejcmanová; Ondřej Májek; Jan Bureš; Miroslav Zavoral; Marek Minárik; Lucie Benešová
Journal:  Cancers (Basel)       Date:  2022-06-07       Impact factor: 6.575

Review 2.  RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer.

Authors:  Valeria Maffeis; Lorenzo Nicolè; Rocco Cappellesso
Journal:  Front Oncol       Date:  2019-11-19       Impact factor: 6.244

Review 3.  The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer.

Authors:  Giuseppe Nicolò Fanelli; Carlo Alberto Dal Pozzo; Ilaria Depetris; Fotios Loupakis; Matteo Fassan; Marta Schirripa; Stefano Brignola; Paola Biason; Mariangela Balistreri; Luca Dal Santo; Sara Lonardi; Giada Munari
Journal:  Cancer Cell Int       Date:  2020-01-29       Impact factor: 5.722

4.  Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/ Polyps with Dysplasia.

Authors:  Rina Fujiwara-Tani; Kiyomu Fujii; Shiori Mori; Shingo Kishi; Takamitsu Sasaki; Hitoshi Ohmori; Chie Nakashima; Isao Kawahara; Yukiko Nishiguchi; Takuya Mori; Masayuki Sho; Masuo Kondoh; Yi Luo; Hiroki Kuniyasu
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

5.  Retrospective study of risk factors for colorectal adenomas and non-adenomatous polyps.

Authors:  Guanqun Chao; Yue Zhu; Lizheng Fang
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

6.  RNA-sequencing identification and validation of genes differentially expressed in high-risk adenoma, advanced colorectal cancer, and normal controls.

Authors:  Namjoo Kim; Jeong-An Gim; Beom Jae Lee; Byung Il Choi; Seung Bin Park; Hee Sook Yoon; Sang Hee Kang; Seung Han Kim; Moon Kyung Joo; Jong-Jae Park; Chungyeul Kim; Han-Kyeom Kim
Journal:  Funct Integr Genomics       Date:  2021-07-17       Impact factor: 3.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.